Global Musculoskeletal Disorders Therapeutics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 3974

Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.
MSDs mostly occur because of the over-exhaustion of weak muscles, ligaments, or tendons. Also, vigorous vocational activities can lead to musculoskeletal pain. Uncured MSDs can result in chronic disruption of the mundane and vocational tasks of the patient. Some of the major therapeutics to treat MSDs include corticosteroids, biologics, parathyroid hormone, selective estrogen receptor modulators, protein therapy, synthetic bone graft, demineralized bone matrix, composite grafts, and BMPS, orthobiologics.
In 2018, the global Musculoskeletal Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Musculoskeletal Disorders Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
AbbVie
Johnson & Johnson
Sanofi
Merck
Novartis
Eli Lilly
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
Amgen
Takeda Pharmaceutical
Daiichi Sankyo
LG Life Sciences
Astellas
Samsung Bioepis
Zosano Pharma
Taisho Pharmaceutical
3SBio

Market segment by Type, the product can be split into
Biologics
Small Molecules
Other

Market segment by Application, split into
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Musculoskeletal Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Musculoskeletal Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Small Molecules
1.4.4 Other
1.5 Market by Application
1.5.1 Global Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2025)
1.5.2 Osteoarthritis
1.5.3 Osteoporosis
1.5.4 Psoriatic Arthritis
1.5.5 Ankylosing Spondylitis
1.5.6 Fibromyalgia
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Musculoskeletal Disorders Therapeutics Market Size
2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Regions
2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Regions (2014-2025)
2.2.2 Musculoskeletal Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Musculoskeletal Disorders Therapeutics Market Size by Manufacturers
3.1.1 Global Musculoskeletal Disorders Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Musculoskeletal Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Musculoskeletal Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
5.2 Musculoskeletal Disorders Therapeutics Key Players in United States
5.3 United States Musculoskeletal Disorders Therapeutics Market Size by Type
5.4 United States Musculoskeletal Disorders Therapeutics Market Size by Application

6 Europe
6.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
6.2 Musculoskeletal Disorders Therapeutics Key Players in Europe
6.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Type
6.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Application

7 China
7.1 China Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
7.2 Musculoskeletal Disorders Therapeutics Key Players in China
7.3 China Musculoskeletal Disorders Therapeutics Market Size by Type
7.4 China Musculoskeletal Disorders Therapeutics Market Size by Application

8 Japan
8.1 Japan Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
8.2 Musculoskeletal Disorders Therapeutics Key Players in Japan
8.3 Japan Musculoskeletal Disorders Therapeutics Market Size by Type
8.4 Japan Musculoskeletal Disorders Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
9.2 Musculoskeletal Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Application

10 India
10.1 India Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
10.2 Musculoskeletal Disorders Therapeutics Key Players in India
10.3 India Musculoskeletal Disorders Therapeutics Market Size by Type
10.4 India Musculoskeletal Disorders Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
11.2 Musculoskeletal Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Type
11.4 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Musculoskeletal Disorders Therapeutics Introduction
12.1.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 AbbVie
12.2.1 AbbVie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Musculoskeletal Disorders Therapeutics Introduction
12.2.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.2.5 AbbVie Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Musculoskeletal Disorders Therapeutics Introduction
12.3.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Musculoskeletal Disorders Therapeutics Introduction
12.4.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Musculoskeletal Disorders Therapeutics Introduction
12.5.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Musculoskeletal Disorders Therapeutics Introduction
12.6.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Musculoskeletal Disorders Therapeutics Introduction
12.7.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Musculoskeletal Disorders Therapeutics Introduction
12.8.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Musculoskeletal Disorders Therapeutics Introduction
12.9.4 Boehringer Ingelheim Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 F. Hoffmann-La Roche
12.10.1 F. Hoffmann-La Roche Company Details
12.10.2 Company Description and Business Overview
12.10.3 Musculoskeletal Disorders Therapeutics Introduction
12.10.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.10.5 F. Hoffmann-La Roche Recent Development
12.11 Amgen
12.12 Takeda Pharmaceutical
12.13 Daiichi Sankyo
12.14 LG Life Sciences
12.15 Astellas
12.16 Samsung Bioepis
12.17 Zosano Pharma
12.18 Taisho Pharmaceutical
12.19 3SBio

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details